Skip to main content
. 2018 Sep 4;18:180. doi: 10.1186/s12872-018-0914-1

Table 1.

Baseline Characteristics of Study Participants Overall and by Glycated Hemoglobine categories

Overall
(N = 19,140)
< 6
(N = 4304)
6–6.5
(N = 3773)
6.5–7
(N = 3339)
7–7.5
(N = 2399)
> = 7.5
(N = 5325)
p-trend
Age, years; mean 65.1 (0.1) 65.4 (0.2) 66.2 (0.2) 66 (0.2) 66.2 (0.2) 62.9 (0.2) < 0.001
Men; % 54.3 (0.4) 54.8 (0.8) 50 (0.8) 51.4 (0.9) 53.3 (1) 59 (0.7) < 0.001
Obesity; % 49.6 (0.4) 47.4 (0.8) 51.5 (0.8) 49.3 (0.9) 49.7 (1) 50.1 (0.7) 0.098
BMI, kg/m2; mean 30.4 (0) 30.2 (0.1) 30.6 (0.1) 30.4 (0.1) 30.5 (0.1) 30.5 (0.1) 0.05
Former smoking; % 23.4 (0.3) 24 (0.7) 23.2 (0.7) 22.6 (0.7) 22.9 (0.9) 23.8 (0.6) 0.875
Current smoking; % 21.6 (0.3) 18.5 (0.6) 18.4 (0.6) 20.1 (0.7) 20.5 (0.8) 27.8 (0.6) < 0.001
Glucose lowering medication; % 51.8 (0.4) 38.8 (0.7) 45.6 (0.8) 52 (0.9) 60 (1) 62.8 (0.7) < 0.001
Hypertension; % 83.2 (0.3) 83.8 (0.6) 84.1 (0.6) 84.4 (0.6) 83.6 (0.8) 81 (0.5) < 0.001
Antihypertensive medication; % 49 (0.4) 50.4 (0.8) 50.2 (0.8) 52.4 (0.9) 50.3 (1) 44.3 (0.7) < 0.001
Systolic blood pressure, mmHg; mean 138 (0.1) 136.1 (0.3) 137 (0.3) 138.3 (0.3) 138.8 (0.4) 139.9 (0.3) < 0.001
Diastolic blood pressure, mmHg; mean 78.6 (0.1) 78 (0.2) 78.3 (0.2) 78.7 (0.2) 78.3 (0.2) 79.4 (0.1) < 0.001
High cholesterol; % 16.7 (0.3) 18.1 (0.6) 17.2 (0.6) 16.8 (0.7) 16.8 (0.8) 15 (0.5) < 0.001
Total cholesterol, mg/dL; mean 197.5 (0.3) 195.5 (0.6) 197 (0.7) 196.3 (0.7) 194.3 (0.8) 201.8 (0.6) < 0.001
HDL-cholesterol, mg/dL; mean 48.9 (0.1) 50.3 (0.2) 49.9 (0.2) 49.4 (0.2) 48.6 (0.3) 46.8 (0.2) < 0.001
LDL-cholesterol, mg/dL; mean 116.6 (0.2) 116.1 (0.5) 116.3 (0.5) 115.3 (0.6) 113.7 (0.7) 119.3 (0.5) < 0.001
Lipid lowering medication; % 38 (0.3) 35.6 (0.7) 39.2 (0.8) 40.1 (0.9) 40.7 (1) 36.6 (0.7) 0.458